| Literature DB >> 33917629 |
Virgil Schijns1,2, Dragomira Majhen3, Peter van der Ley1, Aneesh Thakur4, Artur Summerfield5,6, Rita Berisio7, Cristina Nativi8, Alberto Fernández-Tejada9,10, Carmen Alvarez-Dominguez11, Sveinbjörn Gizurarson12,13, Alla Zamyatina14, Antonio Molinaro15,16, Camillo Rosano17, Žiga Jakopin18, Ihsan Gursel19, Siobhán McClean20.
Abstract
Vaccines are the most effective medical intervention due to their continual success in preventing infections and improving mortality worldwide. Early vaccines were developed empirically however, rational design of vaccines can allow us to optimise their efficacy, by tailoring the immune response. Establishing the immune correlates of protection greatly informs the rational design of vaccines. This facilitates the selection of the best vaccine antigens and the most appropriate vaccine adjuvant to generate optimal memory immune T cell and B cell responses. This review outlines the range of vaccine types that are currently authorised and those under development. We outline the optimal immunological correlates of protection that can be targeted. Finally we review approaches to rational antigen selection and rational vaccine adjuvant design. Harnessing current knowledge on protective immune responses in combination with critical vaccine components is imperative to the prevention of future life-threatening diseases.Entities:
Keywords: adjuvant; antigen; delivery system; design; immunization; rational; route; vaccine
Year: 2021 PMID: 33917629 DOI: 10.3390/pharmaceutics13040501
Source DB: PubMed Journal: Pharmaceutics ISSN: 1999-4923 Impact factor: 6.321